| OC - Naloxone en vaporisateur nasal - Emergent BioSolutions Canada IncCW2464479:0 | Department of Public Works and Government Services (PSPC) | 3 M $ | 20 août 2026 |
| Antitoxine botulique heptavalente (BAT) Substance médicamenteuse en vracCW2442063:0 | Department of Public Works and Government Services (PSPC) | 18,6 M $ | 26 févr. 2026 |
| Anthrasil - Immunoglobuline anthrax (humain) pour perfusionCW2341268:2 | Department of Public Works and Government Services (PSPC) | 1,7 M $ | 14 déc. 2023 |
| Vaporisateur nasal de naloxoneCW2247924:0 | Department of Public Works and Government Services (PSPC) | 702,1 k $ | 17 nov. 2022 |
| AnthrasilCW2237423:4 | Department of Public Works and Government Services (PSPC) | 11,1 M $ | 18 oct. 2022 |
| Naloxone en vaporisateur nasal 4mg5A240-215031:001:PH:0 | Public Works and Government Services Canada | 3 M $ | 7 févr. 2022 |
| Immunoglobuline intraveineuse contre le virus de la vaccine (VIG)6D024-214840:001:PH:0 | Public Works and Government Services Canada | 10,8 M $ | 6 janv. 2022 |
| Vaporisateur nasal de naloxone - Accord cadreE60PH-21NARN:0 | Department of Public Works and Government Services (PSPC) | 0 $ | 3 août 2021 |
| Modif 005 - Vaporisateur nasal de naloxone - EMERGENT BIOSOLUTIONS CANADA INC.E60PH-21NARN:001:PH:6 | Department of Public Works and Government Services (PSPC) | 20 M $ | 3 août 2021 |
| Modif 004 - vaccin Anthrasil - EMERGENT BIOSOLUTIONS CANADA INC.6D024-203933:001:PH:1 | Department of Public Works and Government Services (PSPC) | 10,3 M $ | 20 juill. 2021 |
| Modif 003 - RSDL® - Emergent Biosolutions Canada Inc.W6369-20A021:001:PH:1 | Department of Public Works and Government Services (PSPC) | 18 309 $ | 16 janv. 2020 |
| Produits pharmaceutiques et biologiquesW6369-18A005:001:PH:0 | Public Works and Government Services Canada | 10,3 M $ | 8 déc. 2017 |
| Produits pharmaceutiques et biologiquesW6369-18A002:001:PH:0 | Public Works and Government Services Canada | 382,1 k $ US | 10 juill. 2017 |